Search

CN

搜索
imgboxbg

News Center

Healthy Biotech: CE Certification to Nine Hematological Malignancy Diagnostic Products!

  • Time of issue:  08/07/2023
  • Author:  Healthy Biotech

(Summary description)Healthy Biotech, a subsidiary holding of Kindstar Globalgene Technology Inc., is CE certified for nine of its hematological malignancy diagnostic products, indicating that our products comply with the

Healthy Biotech: CE Certification to Nine Hematological Malignancy Diagnostic Products!

(Summary description)Healthy Biotech, a subsidiary holding of Kindstar Globalgene Technology Inc., is CE certified for nine of its hematological malignancy diagnostic products, indicating that our products comply with the

  • Categories:Company News
  • Author:Healthy Biotech
  • Origin:
  • Time of issue:
  • Views:
Information

Healthy Biotech, a subsidiary holding of Kindstar Globalgene Technology Inc., is CE certified for nine of its hematological malignancy diagnostic products, indicating that our products comply with the regulatory requirements of the European Union and can be sold in the EU as well as countries that recognize CE certification. The nine products are as follows:  

 

● Lymphoma Gene Mutation Detection Kit (RTS)

● Myeloid Tumor Gene Mutation Detection Kit (RTS)

● Clinical Exome Sequencing Detection Kit (RTS)

● T-cell Receptor Gene Rearrangements Clonality Assessment and Minimal Residual Disease Detection Kit (RTS)

● Immunoglobulin Gene Rearrangements Clonality Assessment and Minimal Residual Disease Detection Kit (RTS)

● BCR-ABL1 Fusion Gene Qualitative Detection Kit (PCR-fluorescence probing)

● PML-RARA Fusion Gene Qualitative Detection Kit (PCR-fluorescence probing)

● RUNX1-RUNX1TA Fusion Gene Qualitative Detection Kit (PCR-fluorescence probing)

● Human JAK2-V617F Mutation Detection Kit (PCR-fluorescence probing)

 

These nine kits can be used for clinical diagnosis, prognosis evaluation and targeted therapy of lymphoma, myeloid malignancies, myeloproliferative neoplasms (MPN), chronic myelocytic leukemia (CML), acute myeloid leukemia (AML), etc.

Scan the QR code to read on your phone

Share to:

News Recommendation

Time of issue 11/29/2023
On Jun. 10, the 15th China Bioindustry Conference was held at the Optics Valley Convention & Exhibition Center in Wuhan. It is reported that the China Bioindustry Conference is the highest-level, largest-scale, and most influential conference in the field of bioindustry in China. It was first held in 2007 and, since 2018, has been held alternately in Guangzhou and Wuhan. To date, it has been successfully conducted for fourteen sessions.
See more information 白箭头
Time of issue 11/29/2023
With the strong support from the NDRC and other relevant departments, the 15th China Bioindustry Conference, cosponsored by the People's Government of Hubei Province, 18 National Societies (Associations) including Chinese Society of Biotechnology and the China Science Daily, and organized by the Wuhan Municipal People's Government, will be held at China Optics Valley Convention & Exhibition Center in Wuhan, Hubei Province from Jun. 9 to 12, 2023.
See more information 白箭头
Time of issue 11/29/2023
On May 30, the 20th China Association of Clinical Laboratory Practice Expo (CACLP) officially ended at the Nanchang Greenland International Expo Center. As a flagship exposition in the field of IVD, this year's CACLP has gathered more than 1,300 IVD enterprises, attracting tens of thousands of industry insiders to visit and exchange opinions.
See more information 白箭头

Copyright:Wuhan Healthy Biotechnology Co., Ltd.